- JP-listed companies
- Nissui Pharmaceutical Co., Ltd.
- Income statement
Nissui Pharmaceutical Co., Ltd.【JP:E00971】Income statement
Market cap
P/E ratio
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | |
| Revenue | 13,389 | 13,190 | 13,141 | 11,863 | 12,015 | 12,825 | 12,329 | 12,549 | 12,773 | 12,384 | 16,657 |
| Cost of revenue | - | - | - | 5,929 | 5,847 | 6,442 | 6,476 | 6,791 | 7,047 | 8,186 | 11,399 |
| Gross profit | - | - | - | 5,934 | 6,168 | 6,384 | 5,853 | 5,758 | 5,725 | 4,197 | 5,258 |
| Gross margin (%) | - | - | - | ||||||||
| Operating expenses | - | - | - | 4,022 | 4,175 | 4,686 | 4,425 | 4,445 | 4,580 | 3,404 | 3,694 |
| Operating income | - | - | - | 1,913 | 1,994 | 1,698 | 1,427 | 1,312 | 1,144 | 793 | 1,564 |
| Income before tax | 2,858 | 3,172 | 3,644 | 3,831 | 2,999 | 1,839 | 1,535 | 1,385 | 991 | 944 | 1,593 |
| Provision for income taxes | - | - | - | 1,250 | 875 | 681 | 515 | 597 | 240 | 284 | 503 |
| Net income | 1,616 | 2,232 | 2,306 | 2,471 | 2,041 | 1,903 | 1,175 | 784 | 401 | 648 | 1,146 |
| Earnings per share | 72.14 | 99.65 | 102.95 | 110.33 | 91.14 | 84.97 | 52.5 | 35.05 | 17.95 | 28.95 | 51.2 |
| Dividend per share | 28 | 32 | 36 | 40 | 40 | 40 | 40 | 40 | 30 | 30 | 40 |